Skip to main content

Advertisement

Table 1 Comparison of the general conditions between the two groups \( \left[\overline{x}\kern0.5em \pm \kern0.5em \mathrm{s}/\mathrm{case}\ \left(\%\right)\right] \)

From: Effect of lipid metabolism disorder on liver function in patients with malignant tumors after chemotherapy: a case-control study

Item Observation (n = 265) Control (n = 163) P
Age 62.0 ± 9.3 61.3 ± 9.0 0.247
Male 123 (46.4) 76 (46.6) 0.996
BMI 22.2 ± 2.0 21.8 ± 2.6 0.086
Tumor types
Gastrointestinal cancer 105 (39.6) 61 (37.4) 0.650
Lung cancer 47 (17.7) 37 (22.7) 0.209
Breast cancer 56 (21.1) 32 (19.6) 0.709
Gynecologic cancer 25 (9.4) 16 (9.8) 0.896
Malignant lymphoma 10 (3.8) 6 (3.7) 0.961
Other tumors 22 (8.3) 11 (6.7) 0.559
Surgery 182 (68.7) 116 (71.2) 0.587
ALT before chemotherapy 26.2 ± 7.8 25.4 ± 9.4 0.361
TC before chemotherapy 5.5 ± 1.2 4.7 ± 0.7 0.000
TG before chemotherapy 1.8 ± 0.6 1.3 ± 0.2 0.000
HDL before chemotherapy 1.3 ± 0.5 1.4 ± 0.4 0.000
LDL before chemotherapy 3.2 ± 1.1 2.9 ± 0.8 0.010
  1. BMI body mass index, ALT alanine aminotransferase, TC total cholesterol, TG triglycerides, HDL high-density lipid, LDL low-density lipoprotein; P < 0.05 was considered statistically significant